Jong-Kyun Kim
Amministratore Delegato presso PROGEN CO., LTD.
Patrimonio netto: 259 711 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Jong-Kyun Kim
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jong-Kyun Kim tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Michigan State University | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| YUNGJIN PHARM. CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| PANSTAR ENTERPRISE CO.,LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
| PT KALBE FARMA TBK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Hanyang University | College/University | Corporate Officer/Principal | |
| Ewha Womans University | College/University | Corporate Officer/Principal | |
| Sungkyunkwan University | College/University | Corporate Officer/Principal | |
| University of Indonesia | College/University | Undergraduate Degree | |
| GENEXINE, INC. | Biotechnology | Director/Board Member | |
PT Sanghiang Perkasa
 PT Sanghiang Perkasa Pharmaceuticals: OtherHealth Technology Part of PT Kalbe Farma Tbk, PT Sanghiang Perkasa is an Indonesian company that manufactures and markets nutritional products. The company is based in Jakarta, Indonesia. | Pharmaceuticals: Other | Chairman | |
PT Dankos Farma
 PT Dankos Farma Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, PT Dankos Farma is an Indonesian pharmaceutical company that manufactures pharmaceutical products. The company is based in Jakarta Timur, Indonesia. Mulialie has been the CEO of the company since 2020. | Pharmaceuticals: Major | Sales & Marketing | |
PT Bifarma Adiluhung
 PT Bifarma Adiluhung Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, PT Bifarma Adiluhung is an Indonesian biotechnology company that provides clinically proven and guaranteed biopharmaceutical generics. The company is based in Jakarta Pusat, Indonesia. The CEO of the company is Sie Djohan. | Pharmaceuticals: Major | Chief Executive Officer | |
Innogene Kalbiotech Pte Ltd.
 Innogene Kalbiotech Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of PT Kalbe Farma Tbk, Innogene Kalbiotech Pte Ltd. is a Singaporean pharmaceutical company that manufactures and wholesales pharmaceutical products. The company is based in Singapore, Singapore. | Pharmaceuticals: Major | Director/Board Member | |
PT Kalbio Global Medika
 PT Kalbio Global Medika BiotechnologyHealth Technology Part of PT Kalbe Farma Tbk, PT Kalbio Global Medika is an Indonesian company that manufactures and markets biologic drugs. The company is based in Bekasi, Indonesia. The CEO of the company is Sie Djohan. | Biotechnology | Chief Executive Officer | |
| PT Kalgen DNA | Chief Executive Officer | ||
PT Innolab Sains Internasional
 PT Innolab Sains Internasional Medical/Nursing ServicesHealth Services PT Innolab Sains Internasional engages in provision of clinical laboratory services. The company was founded in April 2016 and is headquartered in Jakarta, Indonesia. | Medical/Nursing Services | Chairman | |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Indonesia | 10 |
| Corea del Sud | 7 |
| Stati Uniti | 3 |
| Singapore | 2 |
Settori
| Health Technology | 10 |
| Consumer Services | 7 |
| Producer Manufacturing | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 9 |
| Corporate Officer/Principal | 6 |
| Chairman | 4 |
| Chief Executive Officer | 4 |
| Doctorate Degree | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Sie Djohan | 11 |
| Chang-Joon Song | 6 |
| Young-Dae Yoon | 5 |
| Sang-Heon Cho | 1 |
| Hyun-Tak Jin | 1 |
| Ko-Yeon Kim | 1 |
| Jae-Yong Kim | 1 |
- Borsa valori
- Insiders
- Jong-Kyun Kim
- Connessioni Società
